Clinical Trial Update: Toripalimab Combined With Double Platinum-based Chemotherapy for Initially Unresectable NSCLC [Phase 2]

View source ↗

Summary

Phase 2 trial results on toripalimab combined with double platinum-based chemotherapy for initially unresectable advanced non-small cell lung cancer have been r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Platinum-based chemotherapy (platinum-based chemotherapy)
• Toripalimab (Toripalimab)

Snippet

Sponsor: Yongchang Zhang | Conditions: Advanced Non Small Cell Lung Cancer | Phase 2 | Status: COMPLETED